Healthy Extracts Reports Record 2025 Revenue
Analysis based on 7 articles · First reported Apr 02, 2026 · Last updated Apr 08, 2026
The positive financial results and strategic initiatives of Healthy Extracts Inc., including the Gummy USA merger and new product launches, are expected to drive significant revenue growth and enhance shareholder value. The planned Nasdaq-100 uplisting for Healthy Extracts Inc. could increase liquidity and institutional investor interest, positively impacting its stock price.
Healthy Extracts Inc. reported audited financial results for the year ended December 31, 2025, with net revenue increasing 45% to a record $4.5 million. This growth was primarily driven by the strategic merger with Gummy USA, which expanded Healthy Extracts Inc.'s manufacturing capabilities and product lines in precision-dosed nutraceutical gummies. Following the merger, Don R. Swanson, Gummy USA's founder, was appointed CEO and chairman of Healthy Extracts Inc. The company also launched several new products, including STAT10 for heart health, 4Sleep for sleep support, and the WHITNEY JOHNS Gut Health Straw in partnership with Whitney Johns. Additionally, Healthy Extracts Inc. expanded its partnership with Gelteq Limited, becoming its exclusive North American manufacturing and fulfillment partner. The company projects overall net revenues to exceed $20 million in 2026 and plans a Nasdaq-100 uplisting to further enhance shareholder value.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard